Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02798419 · ClinicalTrials.gov registry record · Phase 2
Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
A Phase 2 study of Common Warts, sponsored by Dr. Reddys Laboratories.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
- 12
- Study locations
NCT02798419: Completed Phase 2 study of Common Warts, sponsored by Dr. Reddys Laboratories.
NCT02798419 is a Phase 2 study of Common Warts that has completed, run by Dr. Reddys Laboratories. The registered enrollment target is 50 participants, below the 141-participant average among 3 other Common Warts trials with a reported enrollment target (65% lower). The trial reports 12 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02798419, a Phase 2 study of Common Warts, has completed, sponsored by Dr. Reddys Laboratories.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
- 12
- Study locations
Study Summary
DFD05 vs. Active01 in the treatment of common warts
Conditions Studied
Interventions
- DRUG DFD05 Cream
- DRUG Active01 Cream
Study Locations (12)
California
- Investigational Site #4 - Fremont
- Investigational Site #11 - Sacramento
Texas
- Investigational Site #5 - Austin
- Investigational Site #7 - College Station
Arkansas
- Investigation Site #1 - Hot Springs
Colorado
- Investigational Site #2 - Colorado Springs
Florida
- Investigational Site #12 - Tampa
Georgia
- Investigational Site #9 - Marietta
Illinois
- Investigational Site #3 - Arlington Hts
Louisiana
- Investigational Site #10 - Crowley
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-01 |
| Est. Completion | 2016-08 |
| Phase | Phase 2 |
What the finished NCT02798419 record still lists
NCT02798419 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 141-participant average among 3 other Common Warts trials with a reported enrollment target (65% lower).
The record links to 1 condition, with Common Warts appearing as the primary indexed condition, and to 2 interventions - of which DFD05 Cream is the first listed.
NCT02798419 lists 12 locations in 10 states (California, Texas, Arkansas).
Frequently Asked Questions
What is clinical trial NCT02798419 about?
NCT02798419 is a clinical study titled "Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts". DFD05 vs. Active01 in the treatment of common warts
What is the current status of trial NCT02798419?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2016-01. Estimated completion is 2016-08.
What conditions does trial NCT02798419 study?
This clinical trial studies the following conditions: Common Warts.
What interventions are being tested in trial NCT02798419?
The interventions under investigation include: DFD05 Cream (DRUG), Active01 Cream (DRUG).
Who is sponsoring clinical trial NCT02798419?
This trial is sponsored by Dr. Reddys Laboratories, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02798419 being conducted?
This trial has 12 study locations across Arkansas, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Common Warts
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia